两家公司宣布,合并后的公司更名为“tras Pharma, Inc.”,由新任首席执行官Werner Cautreels领导,将于周三在纳斯达克上市交易,股票代码为“TRAW”。
TRAW即将到来的里程碑包括在2024年下半年开始...查看全文
$Onconova医疗(ONTX)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2019-09-20 AccNo: 0001013594-19-000537 Size: 81 KB 网页链接
$Onconova医疗(ONTX)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2019-09-17 AccNo: 0001104659-19-050424 Size: 453 KB 网页链接
$Onconova医疗(ONTX)$ FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses Filed: 2019-09-13 AccNo: 0001104659-19-050158 Size: 3 MB 网页链接
$Onconova医疗(ONTX)$ 内部交易: 2019-09-11,10% Owner,TYNDALL CAPITAL PARTNERS L P ,卖出,1247普通股, $2.75
$Onconova医疗(ONTX)$ 8-K - Current report Filed: 2019-09-13 AccNo: 0001104659-19-050125 Size: 25 KBItem 1.02: Termination of a Material Definitive Agreement 网页链接
$Onconova医疗(ONTX)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2019-09-13 AccNo: 0001104659-19-050126 Size: 421 KB 网页链接
$Onconova医疗(ONTX)$ 内部交易: 2019-09-09,10% Owner,TYNDALL CAPITAL PARTNERS L P ,卖出,400普通股, $2.77
$Onconova医疗(ONTX)$ 内部交易: 2019-09-06,10% Owner,TYNDALL CAPITAL PARTNERS L P ,卖出,5015普通股, $2.78
$Onconova医疗(ONTX)$ 内部交易: 2019-09-05,10% Owner,TYNDALL CAPITAL PARTNERS L P ,卖出,400普通股, $2.75
$Onconova医疗(ONTX)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2019-08-22 AccNo: 0001104659-19-046971 Size: 125 KB 网页链接